Recent Articles

EOG Resources’ Target, Estimates Boosted at Goldman Sachs (EOG)

Natural gas producer EOG Resources, Inc. ( EOG ) on Friday saw its price target and earnings estimates raised by analysts at Goldman Sachs. The firm maintained its “Buy” rating on EOG and boosted its price target from $117 to $121. That new target implies a 16% upside to the stock’s Thursday closing price of $104.22. Goldman also raised its earnings estimates for the company through 2013, following its better-than-expected fourth quarter earnings results. The analyst commented, “EOG remains a leader in developing horizontal resource plays, and the combination of superior liquids growth (28% expected CAGR 2011-14), superior cash-on-cash returns (13.7% 2011-14 avg) and exploration upside as reasons why EOG should not trade at a discounted EV/EBITDA multiple vs. peers.” EOG Resources shares rose $1.04, or +1%, in premarket trading Friday. The Bottom Line Shares of EOG Resources ( EOG ) have a .59% dividend yield, based on last night’s closing stock price of $104.22. The stock has technical support in the $95-$100 price area. If the shares can firm up, we see overhead resistance around the $110-$114 price levels. EOG Resources, Inc. ( EOG ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Digital Realty Trust Q4 FFO Rises; Forecast Boosted (DLR)

Data center REIT Digital Realty Trust, Inc. ( DLR ) on Friday posted better-than-expected fourth quarter funds from operations and lifted its full-year 2011 forecast. The San Francisco-based company reported fourth quarter funds from operations (FFO) of $102.91 million, or 98 cents per share, compared with $69.43 million, or 79 cents per share, in the year-ago period. Excluding one-time items, adjusted FFO was 96 cents per share. Revenue surged more than 40% from last year to $239 million. On average, Wall Street analysts expected smaller FFO of 91 cents per share, albeit on higher revenue of $242 million. Looking ahead, the company boosted its full-year 2011 FFO guidance to a range of $3.80 to $3.95 per share, while analysts expect $3.85 per share for the year. Digital Realty Trust shares were mostly flat in premarket trading Friday. The Bottom Line We recently added shares of Digital Realty Trust ( DLR ) to our recommended list. The company has a 4.86% dividend yield, based on last night’s closing stock price of $56.02. Digital Realty Trust, Inc. ( DLR ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

CF Industries Q4 Profit Beats View on Rising Fertilizer Demand (CF)

Filed in CF Industries, dividend, earnings, Gold Investing, o, revenue, shares by on February 18, 2011 0 Comments

Fertilizer maker CF Industries Holdings, Inc. ( CF ) late Thursday posted better-than-expected fourth quarter earnings results, aided by strong demand for its products and the addition of sales from its acquisition of rival Terra Nitrogen. The Deerfield, IL-based company reported fourth quarter net income of $200.3 million, or $2.78 per share, compared with $51.4 million, or $1.04 per share, in the year-ago period. Excluding one-time items, adjusted profit was $2.65 per share. Revenue more than doubled from last year to $1.24 billion. On average, Wall Street analysts expected a smaller profit of $2.56 per share, on lower revenue of $1.19 billion. CF Industries shares fell 81 cents, or -0.6%, in premarket trading Friday. The Bottom Line CF Industries ( CF ) has been an “aggressive” recommendation for us, but is not a name we think yield-focused investors should be considering. The company has a .27% dividend yield, based on last night’s closing stock price of $147.81. CF Industries Holdings, Inc. ( CF ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Progress Energy Q4 Profit Slips 19%; Adjusted Net Beats View (PGN)

Filed in dividend, earnings, Gold Investing, Gold Investment, o, revenue, shares by on February 18, 2011 0 Comments

Electric utility operator Progress Energy, Inc. ( PGN ) on Friday said its fourth quarter profit fell 19% from last year on flat revenue, but adjusted results narrowly beat analyst expectations. The Raleigh, NC-based company reported fourth quarter net income of $125 million, or 42 cents per share, compared with $154 million, or 55 cents per share, in the year-ago period. Excluding one-time items, adjusted profit was 45 cents per share. Revenue remained essentially flat from last year at $2.3 billion. On average, Wall Street analysts expected a slightly smaller adjusted profit of 44 cents per share, albeit on slightly higher revenue of $2.4 billion. Looking ahead, the company predicted full-year 2011 earnings to range from $3 to $3.20 per share, while analysts expect $3.14 per share for the year. Progress also noted that its planned acquisition by rival Duke Energy ( DUK ) is still on track to close by the end of the year. Progress Energy shares were mostly flat in premarket trading Friday. The Bottom Line We have been recommending shares of Progress Energy ( PGN ) since Dec.10, 2009, when the stock was trading at $41.18. The company has a 5.40% dividend yield, based on last night’s closing stock price of $45.92. Progress Energy, Inc. ( PGN ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Campbell Soup Shares Plunge after Cutting 2011 Forecast (CPB)

Filed in dividend, earnings, Gold Bullion prices, o, revenue, shares by on February 18, 2011 0 Comments

Packaged foods maker Campbell Soup Company ( CPB ) on Friday posted fiscal second quarter earnings that met analyst expectations, but cut its full-year outlook, sending its shares plummeting in premarket trading. The Camden, NJ-based company reported fiscal second quarter net income of $239 million, or 71 cents per share, compared with $259 million, or 74 cents per share, in the year-ago period. Revenue fell 1% from last year to $2.13 billion. On average, Wall Street analysts expected a matching profit of 71 cents per share, albeit on slightly higher revenue of $2.15 billion. Looking ahead, the company cut its full-year 2011 outlook, citing weaker-than-expected soup sales. It now expects full-year revenue to range from a 1% decline to a 1% rise, and forecast profits to fall 1% to 3%. Campbell Soup shares plunged $1.45, or -4.2%, in premarket trading Friday. The Bottom Line We recently removed shares of Campbell Soup ( CPB ) from our recommended list. The company has a 3.32% dividend yield, based on last night’s closing stock price of $34.94. The stock has technical support in the $30 price area. If the shares can firm up, we see overhead resistance around the $36 price level. Campbell Soup Company ( CPB ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Nordstrom Q4 Profit Jumps 35%; Will Acquire HauteLook for $180 Million (JWN)

Filed in dividend, earnings, Gold, o, revenue, shares by on February 18, 2011 0 Comments

Fashion retailer Nordstrom, Inc. ( JWN ) late Thursday said its fourth quarter profit surged 35% from last year, beating analyst estimates, as the company announced the acquisition of discount luxury website HauteLook. The Seattle-based company reported fourth quarter net income of $232 million, or $1.04 per share, compared with $172 million, or 77 cents per share, in the year-ago period. Revenue rose 10% from last year to $2.92 billion. On average, Wall Street analysts expected a smaller profit of 99 cents per share, on lower revenue of $2.83 billion. Looking ahead, the company forecast full-year 2011 earnings to range from $2.95 to $3.10 per share. Analysts currently expect $3.04 per share for the year. In a separate announcement, Nordstrom said it would buy discount luxury goods website HauteLook for $180 million in stock. Nordstrom shares fell $1.27, or -2.7%, in premarket trading Friday. The Bottom Line Shares of Nordstom ( JWN ) have a 1.72% dividend yield, based on last night’s closing stock price of $46.48. The stock has technical support in the $40-$44 price area. If the shares can firm up, we see overhead resistance around the $50 price level. Nordstrom, Inc. ( JWN ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Market Wrap-Up for Feb.17 (WTW, DPS, CLF, WMB, KO, LO, SJM, more)

Filed in AMAG, Apple, dividend, earnings, Ford, Gold, Gold Bullion prices, lead, o, shares by on February 17, 2011 0 Comments

It was an overall steady day for the markets, along with a decent number of dividend payouts coming over the wires. Earnings boosted several dividend names, but the biggest winner of the day was Weight Watchers ( WTW ) after the company just stunned analysts with the size of its 2011 earnings estimates. Shares of WTW rallied over $20 this morning on that news. Other earnings plays that had a good day included recently-recommended name Dr. Pepper Snapple Group ( DPS ). Cliffs Natural Resources ( CLF ) and J.M. Smucker Company ( SJM ) traded in the green as well following earnings results. Williams Co. ( WMB ) was up on news the company will be splitting in two. The company also announced a dividend boost. Late in the morning, beverage giant Coca-Cola ( KO ) announced a 7% increase in its dividend payout. Tobacco play Lorillard ( LO ) announced a 16% increase in its dividend payout to lift shares almost 2%. We had removed shares of Lorillard from our recommended list recently on concerns we have surrounding the coming FDA judgement/opinion on use of menthol in cigarettes, which accounts for the majority of Lorillard’s sales. I have to admit, I am a big fan of American Idol. My kids and I really enjoy the whole “dreams can come true” mindset for the contestants. Last night was another episode of “cut-downs” as singers needed to perform as part of groups. It’s always interesting to see the type of friction this can cause as egos are clashing everywhere you turn. What amazes me is that often times the individual performers that we thought were amazing on their own, begin to crumble when taken into a different situation. They lose sight of what needs to be done to get through to the next rounds. You see some completely unravel and throw the opportunity they had once cherished right down the drain. This phenomenon isn’t unlike the investing world in that many individuals know what needs to get done to build wealth, but for some reason or another, can not seize the moment. Whether it is just putting some extra coin to the side every month, spending some money to find quality research and investment ideas, or swallowing their pride when an investment idea doesn’t pan out, investors consistently make big mistakes. I know the market continues to move higher and some people may be waiting for a pullback. There is nothing wrong with doing so, but don’t skip your monthly investments you can be making because of that. There are plenty of good yield plays that you can still find to put money to work in, even after the nice run the market has had. Taking financial responsibility and knowing what you can afford to do is the key. I talk about investing in quality dividend-paying stocks as a great way to build up your future income, but if you are spending like there’s no tomorrow as well, then that is a risk that could eventually negate all the good you might be doing on the investment side. Saving is a mantra that needs to also be adopted…

Continue Reading »

General Electric (GE) Building $550 Million Brazilian Research Center

Filed in Brazil, General Electric, Gold Prices, Jeffrey Immelt, o by on February 17, 2011 0 Comments

With an eye toward expanding its presence in Brazil, General Electric (NYSE:GE) announced it will be building a $550 million research center in Brazil, focusing on IT, energy and health sectors. The center will be built in the state of Rio de Janeiro, according to Brazilian Science and Technology Minister Aloizio Mercadante, who attended a meeting with Brazilian President Dilma Rousseff and GE

Continue Reading »

Semiconductor’s Brocade (BRCD), ON Semi (ONNN) and National (NSM) Jumping Today

Semicondutors Brocade Communications Systems, Inc. (NASDAQ:BRCD), ON Semiconductor Corp. (NASDAQ:ONNN) and National Semiconductor Corporation (NYSE:NSM) are all trading positive today, led by Brocade, which has enjoyed the largest gains in the semi sector today. Brocade Communications Systems, Inc. made the biggest move in anticipation of its earnings report after the market closes. Brocade was

Continue Reading »

Gallup: The Unemployment Rate is 10%

Jobs…jobs…jobs… I’m beginning to sound like a broken record but it’s true: This economy is going nowhere unless we start creating some jobs. As for the recent drop in the unemployment rate to 9.0%, I’m not buying it since it comes from Uncle Sam. The real figure is likely closer to what Gallup is reporting today… From by Dennis Jacobe entitled: Gallup Finds U.S. Unemployment Up to 10% in Mid-February “Unemployment, as measured by Gallup without seasonal adjustment, hit 10.0% in mid-February — up from 9.8% at the end of January. Underemployment, in which Gallup combines part-time workers wanting full-time work with the U.S. unemployment rate, surged in mid-February to 19.6% — mostly as a result of the sharp increase in those working part time but wanting full-time work. Underemployment now stands at basically the same place as it did a year ago (19.8%). The unemployment rate in mid-February is 0.8 percentage points lower than it was at this time a year ago, compared with a 1.1-point improvement at the end of January. This suggests that jobs are less available now than they were in January. More troubling, however, is the surge in underemployment. On this broader basis, current job conditions are barely improved from what they were at this time last year. Essentially, what has happened over the past year is that some people who were unemployed got part-time jobs but are still looking for full-time work. This is not much to show for a year in which many macro-economic indicators showed improvement. This is likely why Gallup’s self-reported spending

Continue Reading »

Fidelity Select Healthcare (FSPHX): The Right Prescription

Filed in Bank Gold, economy, o by on February 17, 2011 0 Comments

Filed under: Newsletters , Mutual Funds “We own a healthy dose of Fidelity Select Healthcare ( FSPHX ) in each of our model portfolios,” says fund expert Jim Lowell . The editor of Fidelity Investor explains, “Manager Eddie Yoon and I caught up this month. His command of the sector and his growth-oriented discipline continue to serve us well on both our risk-adjusted and real return fronts/ “Of course, healthcare (representing nearly 16% of our total GDP) is unlike any other sector in the S&P. It is so diversified and global, so interrelated to technology, manufacturing, and R&D, so dependent upon delivering real goods and services for consumer consumption, that it is almost an economy unto itself. Continue reading Fidelity Select Healthcare (FSPHX): The Right Prescription Fidelity Select Healthcare (FSPHX): The Right Prescription originally appeared on BloggingStocks on Thu, 17 Feb 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Continue Reading »

The Miracle of Regenerative Medicine

Filed in AMAG, BP, Gold, Gold Market, HAL, o, target by on February 17, 2011 0 Comments

Tall, dark, and handsome… Dr. Anthony Atala is not a guy you could easily mistake for Dr. Frankenstein. Yet, in his white lab coat, Atala is doing exactly what author Mary Shelley wrote about so long ago. A mad scientist in his own right, he is busy growing body parts in his Wake Forest lab. A finger here, a bladder there, Atala is currently growing dozens of different tissues. And from heart valves to muscles to ears, his Institute for Regenerative Medicine is literally about to turn the world on its head. Working at one of the world’s largest research facilities dedicated to regenerative medicine, the modern Dr. Frankenstein is adamant that his research will one day replace diseased or damaged tissue using homegrown replacement parts. After all, as Dr. Atala often pondered, “A salamander can grow back its leg, why can’t a human do the same?” Now, some twenty-four years later, that notion is no longer just a wild hypothetical; it’s a feat of modern science, stripped from the pages of a 194-year-old novel. Today, regenerative medicine stocks are the companies to watch as this amazing new technology unfolds. The promise of regenerative medicine Take the story of Claudia Castillo, for instance. In 2008, this 30-year-old mother of two became the first patient to receive a whole organ transplant without the need for powerful anti-rejection drugs. Damaged by a bout of tuberculosis, her entire windpipe was repaired with a replacement part created with the help of her own stem cells. And given the choice between losing a lung or becoming a guinea pig for a radical new medical technique, Castillo chose the latter— becoming one of the pioneers for future regenerative surgeries. Her life these days is not only back to normal… She recently called her doctors from a nightclub to tell them she had been out dancing all night. Before the ground-breaking surgery, Castillo could barely climb the stairs. Claudia’s story is just the beginning… In fact Dr. Atala’s team is currently working on re-growing over 23 different organs including the liver, heart, kidney, and bladder. Along the way, they have conquered a number of milestones in the field. From the website , these firsts include: Developing biological strategies to enable certain human cell types that were previously thought not to be expandable outside the body to be grown in…

Continue Reading »